A large Italian study demonstrates that integrase inhibitor-based antiretroviral regimens are not associated with the risk of developing type 2 diabetes. It also reveals that it is not the weight that people gain while on these drugs, but their weight when they start taking them (at baseline) which is the main factor associated with the onset of diabetes. Another study pooling previously published research on this issue concludes that the risk of diabetes is not increased with these drugs compared with other antiretrovirals, except in African populations.
Read the full story at Aidsmap.
Source : Aidsmap
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.